Expertise in
1
conditions

Paul P. Donnellan

Newcastle Road, 
Gaillimh, C, IE 
Expertise in
1
conditions
Newcastle Road, 
Gaillimh, C, IE 

Overview

Paul Donnellan practices practicing medicine in Gaillimh, Ireland.

Mr. Donnellan is highly rated in 1 condition, according to our data. His clinical expertise encompasses Ovarian Cancer, Melanoma, Renal Cell Carcinoma (RCC), and Breast Cancer.

He is actively involved in clinical research, co-authoring 24 peer reviewed articles and participating in 4 clinical trials.

Gender

Male

Locations

Newcastle Road, Gaillimh, C, Ireland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Randomised, Open-label Phase III Trial Evaluating the Addition of Denosumab to Standard First-line Anticancer Treatment in Advanced NSCLC
A Randomised, Open-label Phase III Trial Evaluating the Addition of Denosumab to Standard First-line Anticancer Treatment in Advanced NSCLC
Enrollment Status: Terminated
Publish Date: September 08, 2026
Intervention Type: Other, Drug
Study Phase: Phase 3
A Phase III Randomized Trial Comparing Physician/Patient Choice of Either High Dose Interferon or Ipilimumab to MK-3475 (Pembrolizumab) in Patients With High Risk Resected Melanoma
A Phase III Randomized Trial Comparing Physician/Patient Choice of Either High Dose Interferon or Ipilimumab to MK-3475 (Pembrolizumab) in Patients With High Risk Resected Melanoma
Enrollment Status: Active_not_recruiting
Publish Date: August 28, 2026
Intervention Type: Other, Procedure, Biological
Study Drugs: Ipilimumab, Pembrolizumab, Recombinant Interferon Alfa-2b
Study Phase: Phase 3
Randomised Phase 3 Trial of Enzalutamide in First Line Androgen Deprivation Therapy for Metastatic Prostate Cancer: ENZAMET
Randomised Phase 3 Trial of Enzalutamide in First Line Androgen Deprivation Therapy for Metastatic Prostate Cancer: ENZAMET
Enrollment Status: Active_not_recruiting
Publish Date: February 06, 2025
Intervention Type: Drug
Study Drugs: Enzalutamide, Non-Steroidal Anti Androgen, Luteinizing Hormone Releasing Hormone Analog or Surgical Castration
Study Phase: Phase 3
A Translational Systems Medicine Approach to Provide Predictive Capacity for Therapy Responsiveness in Advanced or Metastatic Malignant Melanoma (SYS-ACT)
A Translational Systems Medicine Approach to Provide Predictive Capacity for Therapy Responsiveness in Advanced or Metastatic Malignant Melanoma (SYS-ACT)
Enrollment Status: Completed
Publish Date: November 17, 2020
View 3 Less Clinical Trials

24 Total Publications

Prognostic significance and accuracy of oncologists' estimates of survival time in recurrent ovarian cancer.
Prognostic significance and accuracy of oncologists' estimates of survival time in recurrent ovarian cancer.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: September 08, 2024

Frequently Asked Questions about Paul P. Donnellan

Is Paul P. Donnellan a top-rated expert for Ovarian Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Paul P. Donnellan is classified as an Advanced expert for Ovarian Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Paul P. Donnellan participate in research or clinical trials?

Yes. Paul P. Donnellan has published 24 articles and abstracts on conditions like Ovarian Cancer. You can view a list of Paul P. Donnellan's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Donnellan's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile